Mount Sinai’s Dr. Bruce Sands Receives Crohn’s and Colitis Foundation of America’s 2016 Lifetime Achievement Award
Bruce E. Sands, MD, MS, Dr. Burrill B. Crohn Professor of Medicine, Chief of the Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, received the Henry D. Janowitz Lifetime Achievement Award at the 2016 Crohn’s & Colitis Foundation of America (CCFA) Advances in Inflammatory Bowel Diseases Clinical and Research Conference, held December 8-10 in Orlando, FL.
Dr. Sands was nominated by the medical and research community for his exceptional dedication to the field of IBD. For his entire professional career, Dr. Sands has focused his research and clinical care on IBD. He helped to launch the Susan and Leonard Feinstein IBD Clinical Center at Mount Sinai and has been the principal investigator on a number of groundbreaking studies of new therapeutic agents for the treatment of IBD. He has published over 150 peer-reviewed articles on the topic of inflammatory bowel disease, including papers on etiology, diagnosis, prognosis, and treatment.
Dr. Sands previously served as the Chair of the CCFA’s Clinical Research Alliance, and on the National Scientific Advisory Committee. He is a past chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) and has also served as the Chair of the Immunology, Microbiology and Inflammatory Bowel Disease Section of the American Gastroenterological Association. Dr. Sands has been an Associate Editor for the journal Gastroenterology, and is on the Editorial Board of Inflammatory Bowel Diseases.
Before coming to Mount Sinai, Dr. Sands was on the faculty at Massachusetts General Hospital, where he founded and co-directed the MGH Inflammatory Bowel Disease Center and served as Acting Chief of the Gastrointestinal Unit. While in Boston, he served as Chair of the CCFA’s New England Chapter’s Medical Advisory Committee and was awarded Humanitarian of the Year in 2006.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.